MPI Technology Now Available to Medical Researchers in Australia
By MedImaging International staff writers Posted on 17 Jan 2017 |
Image: Magnetic Particle Imaging (MPI) that shows perfusion in the brain of a rat (Photo courtesy of AXT).
Medical researchers in Australia now have access to a new imaging technology called Magnetic Particle Imaging (MPI) that can give researchers improved insight into organ and tissue function, with sensitivity comparable to that of nuclear medicine, the speed of Computed Tomography (CT), and the resolution of Magnetic Resolution Imaging (MRI).
MPI provides improved sensitivity, resolution, and contrast over existing imaging technologies, by using Super Paramagentic Iron Oxide (SPiO) nanoparticles to tag cells anywhere in the body, at any tissue depth. MPI enables researchers to quantify what is actually happening in real time, and in vivo. In addition, MPI does not expose patients to ionizing radiation.
The new technology was part of a partnership agreement between AXT and Magnetic Insights. Momentum, the first MPI system can be used to generate quantitative images that analyze functional responses to drugs and treatments, in oncology, immunology, vascular function, and stem cell research, amongst others. The MPI technology could be used in the future to enable early detection and monitoring of neurovascular diseases such as stroke.
CEO of Magnetic Insight, Dr. Anna Christensen, said, “We are changing the landscape of diagnostic imaging with the impact of what MRI, PET and CT offered over 30 years ago. MPI complements many of the existing imaging modalities but also provides researchers and doctors levels of information that were not previously possible, all without radiation. We look forward to working with the team at AXT to bring this technology to Australia.”
MPI provides improved sensitivity, resolution, and contrast over existing imaging technologies, by using Super Paramagentic Iron Oxide (SPiO) nanoparticles to tag cells anywhere in the body, at any tissue depth. MPI enables researchers to quantify what is actually happening in real time, and in vivo. In addition, MPI does not expose patients to ionizing radiation.
The new technology was part of a partnership agreement between AXT and Magnetic Insights. Momentum, the first MPI system can be used to generate quantitative images that analyze functional responses to drugs and treatments, in oncology, immunology, vascular function, and stem cell research, amongst others. The MPI technology could be used in the future to enable early detection and monitoring of neurovascular diseases such as stroke.
CEO of Magnetic Insight, Dr. Anna Christensen, said, “We are changing the landscape of diagnostic imaging with the impact of what MRI, PET and CT offered over 30 years ago. MPI complements many of the existing imaging modalities but also provides researchers and doctors levels of information that were not previously possible, all without radiation. We look forward to working with the team at AXT to bring this technology to Australia.”
Latest General/Advanced Imaging News
- Bone Density Test Uses Existing CT Images to Predict Fractures
- AI Predicts Cardiac Risk and Mortality from Routine Chest CT Scans
- Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging